Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2008
04/01/2008US7351887 Celery cultivar ADS-11
04/01/2008US7351886 Soybean variety 4812469
04/01/2008US7351885 Soybean variety 4761767
04/01/2008US7351883 Radish cultivar ADS-10
04/01/2008US7351882 Canola line 45H24
04/01/2008US7351881 Expression vector coding bacillus insecticidal protein for use in generating insect resistant plants; tissue engineering; biological pest control
04/01/2008US7351880 Genes and vectors for conferring herbicide resistance in plants
04/01/2008US7351879 Compositions and methods for modulating plant development
04/01/2008US7351878 Introducing into plant an expression cassette comprising promoter operably linked to nucleotide sequence that encodes an antifungal polypeptide; transformation; transgenic seeds and plants; plant disease resistance
04/01/2008US7351877 Lambda integrase mediated recombination in plants
04/01/2008US7351876 Efficient nuclear transfer with primordial gametes
04/01/2008US7351875 Using recombinant rodent which expresses Fc gamma RIIa receptor as tool in identifying modulators for treatment and prevention of arthritic and autoimmune disorders
04/01/2008US7351874 Transgenic animals for use in the treatment of nervous system disorders
04/01/2008US7351819 Using oligonucleotides to detect viral nucleotide sequences in food; diagnosing food poisoning
04/01/2008US7351818 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna
04/01/2008US7351817 For transfecting a plant cell
04/01/2008US7351815 Canine pre-proGHRH and mature GHRH genes
04/01/2008US7351814 Olfactory receptor expression libraries and methods of making and using them
04/01/2008US7351813 Expression vector coding heterologous protein for use in human therapeutics; for treatment of blood nd liver disorders
04/01/2008US7351812 For selecting protein or nucleic acid molecule by linking mRNA, with known or unknown sequences, to its translated protein to form a cognate pair
04/01/2008US7351810 Polypeptides, polynucleotides and uses thereof
04/01/2008US7351804 Antibodies against PRO4421
04/01/2008US7351803 CD16A binding proteins and use for the treatment of immune disorders
04/01/2008US7351795 PRO19563 polypeptides
04/01/2008US7351794 PRO1754 polypeptides
04/01/2008US7351793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
04/01/2008US7351792 G-protein coupled receptor for use as tool in identify modulators which prevent serine protease activation in response to trauma and immune system attack
04/01/2008US7351789 For pharmaceuticals, diagnostics, biosensors and bioreactors
04/01/2008US7351701 Therapeutic compounds
04/01/2008US7351697 Tumor-specific vector for gene therapy
04/01/2008US7351694 Diagnosis of prostate cancer; genetic engineered protein
04/01/2008US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
04/01/2008US7351590 Methods and compositions for directed microwave chemistry
04/01/2008US7351585 Retroviral vector
04/01/2008US7351583 Antibodies to G protein-coupled receptor
04/01/2008US7351582 Cell lines
04/01/2008US7351580 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
04/01/2008US7351578 Microarray comprising two or more immobilized vectors for use as replication and gene transfer tools; simultaneous cloning of two or more nucleotide sequences
04/01/2008US7351577 For hemophilia gene therapy
04/01/2008US7351573 Transgenic cell comprising vetor coding cellulase protein for use in preparing biofuels, detergents, textile treatment and enhancing animal feeds
04/01/2008US7351570 Hepatitis d viral nucleotide sequences for use in diagnosis of hepatitis b infection
04/01/2008US7351569 Such as 4-(Indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate from indole pyruvic acid and pyruvic acid (and/or oxaloacetic acid) by aldolase derived from Pseudomonas, Erwinia, Flavobacterium, and/or Xanthomonas
04/01/2008US7351568 EGVI endoglucanase and nucleic acids encoding the same
04/01/2008US7351565 Plant caffeic acid 3-O-methyltransferase homologs
04/01/2008US7351564 SQS gene
04/01/2008US7351562 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides
04/01/2008US7351560 Glycerol-3-phosphate phosphatase and glycerol-3-phosphate dehydrogenase from Candida albicans, genes encoding the same, vector and host cell containing the genes, and method for producing glycerol using the host cell
04/01/2008US7351557 Amplification of RNA sequences using composite RNA-DNA primers and strand displacement
04/01/2008US7351556 Gene that code for polypeptides having hydrolase activity, produced by genetic engineering and used for producing oligosaccharides, agarooligosaccharides
04/01/2008US7351555 Expression vector comprising nucleotide sequences coding cytokine receptor (Zcytor16) for use as antagonist tool of interleukin-10 related t-cell derived inducible factor in diagnosis, treatment and prevention of cell proliferative and inflammatory disorders
04/01/2008US7351552 Modified pro-α peptides and their uses
04/01/2008US7351551 Adipocyte differentiation-associated gene and protein
04/01/2008US7351550 Exoenzyme toxin of Aeromonas salmonicida, and uses thereof
04/01/2008US7351549 Method for the manufacture of recombinant trypsin
04/01/2008US7351545 Pre-treating breast cancer cells with an IGFBP-3 fragment or fusion protein that binds IGF-I or IGF-II for 24 hours prior to treating the cells with an apoptotic factor( paclitaxel, doxorubicin) and native-sequence human IGFBP-3 or fragment or fusion protein for determining enhancement of apoptosis
04/01/2008US7351536 a transposon-like element specifically present in the rye genome but not present in the wheat genome, for the purpose of breading wheat exhibiting resistance to disease and environmental stress
04/01/2008US7351535 Using cholesterol transport protein to identify modulators which enhance high density lipoprotein concentration in blood
04/01/2008US7351533 Recombinant papilloma virions capable of forming conformational antigenic epitopes for use as therapeutic delivery systems; viricides; antitumor agents
04/01/2008US7351531 Molecules capable of binding to telomere and the like and method with the use of the same
04/01/2008US7351529 Methods for detecting genetic mosaicisms using arrays
04/01/2008US7351528 Detection of preferential nucleotide sequences in sample; obtain sample incubate with probes, detect signal
04/01/2008US7351524 Diagnostics and therapeutics for macular degeneration-related disorders
04/01/2008US7351428 Phosphatidyl oligoglycerols
04/01/2008US7351413 Stabilized HBc chimer particles as immunogens for chronic hepatitis
04/01/2008US7351411 Administering a VEGF antagonist comprising a fusion polypeptide having an immunoglobulin-like (Ig) domain 2 of the VEGF receptor Flt1 and Ig domain 3 of the VEGF receptor Flk1 or Flt4, and a multimerizing component
04/01/2008US7351410 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution
04/01/2008US7351409 Tumor antigens and CTL clones isolated by a novel procedure
04/01/2008US7351378 Nucleic acid extraction device
04/01/2008US7351376 Integrated active flux microfluidic devices and methods
04/01/2008CA2416347C Improvements in or relating to plant starch composition
04/01/2008CA2408223C Plant brassinolide responsive genes and use thereof
04/01/2008CA2316113C Method for nucleic acid purification using iodine
04/01/2008CA2305623C Porcine circovirus, vaccines, and diagnostic reagents
04/01/2008CA2273064C Novel processes for amplifying nucleic acid, post-termination labeling process for nucleic acid sequencing and producing nucleic acid having decreased thermodynamic stability
04/01/2008CA2217173C Isolation of a cdna clone encoding a subunit of the alternaria alternata major allergen alt a 1, and production of recombinant protein thereof
04/01/2008CA2175992C In situ modification and manipulation of stem cells of the central nervous system
04/01/2008CA2140081C Process, construct and conjugate for producing multiple nucleic acid copies
03/2008
03/29/2008CA2586746A1 Discharge volume control method, discharge pressure control method, injecting apparatus, microbody forming method, discharge volume control device, and computer product
03/27/2008WO2008036841A2 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
03/27/2008WO2008036825A2 Duplex oligonucleotide complexes and methods for gene silencing by rna interference
03/27/2008WO2008036776A2 Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
03/27/2008WO2008036765A2 Micrornas differentially expressed in pancreatic diseases and uses thereof
03/27/2008WO2008036741A2 Mir-200 regulated genes and pathways as targets for therapeutic intervention
03/27/2008WO2008036718A2 Mir-143 regulated genes and pathways as targets for therapeutic intervention
03/27/2008WO2008036638A2 Rnai modulation of scap and therapeutic uses thereof
03/27/2008WO2008036392A2 Genetically programmed expression of selectively sulfated proteins in eubacteria
03/27/2008WO2008036255A2 A facs-and reporter protein-based system for high throughput development of therapeutic proteins
03/27/2008WO2008036127A2 Oligonucleotide analogs having cationic intersubunit linkages
03/27/2008WO2008035787A1 Method of coating charged polymer with metal
03/27/2008WO2008035702A1 Method for selection of hop strain, bleeding marker for use in selection of hop strain, and primer set
03/27/2008WO2008035692A1 Cancer cell identification marker and cancer cell proliferation inhibitor
03/27/2008WO2008035527A1 ANTI-C1q MONOCLONAL ANTIBODY
03/27/2008WO2008035463A1 Antibody class switching method
03/27/2008WO2008035462A1 Transgenic plant without exogenous gene and method for producing the same
03/27/2008WO2008035291A2 A double stranded rna oligonucleotide: a pharmaceutical or cosmetic composition containing it and its use as an active pharmaceutical ingredient in the treatment of androgen-related diseases
03/27/2008WO2008035096A1 Assay
03/27/2008WO2008034891A2 Novel genes related to glutaminyl cyclase
03/27/2008WO2008034881A1 Protease resistant insulin analogues
03/27/2008WO2008034876A1 Method for increasing the pathogen resistance in transgenic plants
03/27/2008WO2008034866A2 Dbait and uses thereof